‘EXPANDING RAPIDLY AND OPENING NEW LABS’

“We have a task force set-up to tap the B2B segments especially in the esoteric specialised and superspecialised space. This has traditionally been our bread-andbutter segment and we will grow it. At the same time, we remain focused to tap the B2C segment. Getting closer to the customer is the new mantra. We are expanding rapidly, opening labs and collection centres across the country. Our systems are ready, our manpower is ready, and our infrastructure is falling in place. You will definitely see Oncquest amongst the highest growth organisations in 2022.” - DR RAVINDER DEEP SINGH SETHI, Chief Operating Officer, Oncquest Laboratories, New Delhi